Trial · NCT00059839
Adverse events314
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 314
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Standard (APO) With Vincristine (Arm I) | 14 | 64 | 14 |
| other | Anemia | Blood and lymphatic system disorders | Consolidation (Includes Vinblastine) (Arm II) | 24 | 61 | 24 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Standard (APO) With Vincristine (Arm I) | 0 | 64 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Consolidation (Includes Vinblastine) (Arm II) | 1 | 61 | 1 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Standard (APO) With Vincristine (Arm I) | 7 | 64 | 7 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Consolidation (Includes Vinblastine) (Arm II) | 18 | 61 | 18 |
| other | Cardiac disorders - Other | Cardiac disorders | Standard (APO) With Vincristine (Arm I) | 2 | 64 | 2 |
| other | Cardiac disorders - Other | Cardiac disorders | Consolidation (Includes Vinblastine) (Arm II) | 0 | 61 | 0 |
| other | Conduction disorder | Cardiac disorders | Standard (APO) With Vincristine (Arm I) | 1 | 64 | 1 |
| other | Conduction disorder | Cardiac disorders | Consolidation (Includes Vinblastine) (Arm II) | 0 | 61 | 0 |
| other | Sinus tachycardia | Cardiac disorders | Standard (APO) With Vincristine (Arm I) | 0 | 64 | 0 |
| other | Sinus tachycardia | Cardiac disorders | Consolidation (Includes Vinblastine) (Arm II) | 3 | 61 | 3 |
| other | Middle ear inflammation | Ear and labyrinth disorders | Standard (APO) With Vincristine (Arm I) | 1 | 64 | 1 |
| other | Middle ear inflammation | Ear and labyrinth disorders | Consolidation (Includes Vinblastine) (Arm II) | 0 | 61 | 0 |
| other | Blurred vision | Eye disorders | Standard (APO) With Vincristine (Arm I) | 0 | 64 | 0 |
| other | Blurred vision | Eye disorders | Consolidation (Includes Vinblastine) (Arm II) | 1 | 61 | 1 |
| other | Cataract | Eye disorders | Standard (APO) With Vincristine (Arm I) | 0 | 64 | 0 |
| other | Cataract | Eye disorders | Consolidation (Includes Vinblastine) (Arm II) | 1 | 61 | 1 |
| other | Eye disorders - Other | Eye disorders | Standard (APO) With Vincristine (Arm I) | 0 | 64 | 0 |
| other | Eye disorders - Other | Eye disorders | Consolidation (Includes Vinblastine) (Arm II) | 1 | 61 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00059839/events